BRCA2 germline mutations in familial pancreatic carcinoma
Abstract
BACKGROUND: Although as many as 10% of pancreatic cancer cases may have an inherited component, familial pancreatic cancer has not been linked to defects in any specific gene. Some studies have shown that families with germline mutations in the breast cancer susceptibility gene BRCA2 have an increased risk of breast and ovarian cancers, as well as a modestly increased risk of pancreatic cancer. To study these relationships in more detail, we examined whether BRCA2 germline mutations are associated with familial pancreatic cancer. METHODS: We identified 26 European families in which at least two first-degree relatives had a histologically confirmed diagnosis of pancreatic ductal adenocarcinoma. We sequenced genomic DNA isolated from peripheral blood lymphocytes obtained from participating family members to identify germline mutations in BRCA2. RESULTS: Three (12%, exact 95% confidence interval [CI] = 2% to 30%) families carried germline frameshift mutations in the BRCA2 gene that are predicted to result in a truncated BRCA2 protein. Two additional families harbored mutations previously designated as unclassified variants of BRCA2. Thus, 19% (exact 95% CI = 7% to 39%) of the families in our study had either a frameshift mutation or an unclassified variant of BRCA2. None of the families in our study met the criteria for familial breast or ovarian cancer. CONCLUSIONS: Our data support an important role for BRCA2 germline mutations in a subpopulation of families with familial pancreatic cancer. BRCA2 mutation analysis should be included in molecular genetic testing and counseling strategies in families with at least two first-degree relatives affected with ductal adenocarcinoma of the pancreas.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169 · see citing works
Linkage disequilibrium in the human genome
Reich, D., Cargill, M., Gabriel, S., Ireland, J. S., Sabeti, P. C., Richter, D. J., Lavery, T., Kouyoumjian, R., Farhadian, S., Ward, R. H., et al. (2001) · Nature · doi:10.1038/35075590 · Cited by 1,763 · see citing works
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713 · see citing works
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,652 · see citing works
Very high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435 · see citing works
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,319 · see citing works
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240 · see citing works
Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase
Jenne, D. E., Reomann, H., Nezu, J., Friedel, W., Loff, S., Jeschke, R., Müller, O., Back, W. E., & Zimmer, M. (1998) · Nature Genetics · doi:10.1038/ng0198-38 · Cited by 1,201 · see citing works
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132 · see citing works
Lynch, H. T., Smyrk, T. C., Watson, P. A., Lanspa, S. J., Lynch, J. F., Lynch, P. M., Cavalieri, R. J., & Boland, C. R. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90368-m · Cited by 1,065 · see citing works
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Perrault, J., Whitcomb, D. C., & International Hereditary Pancreatitis Study Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.442 · Cited by 988 · see citing works
Increased Risk of Cancer in the Peutz–Jeghers Syndrome
Giardiello, F. M., Welsh, S. B., Hamilton, S. R., Offerhaus, G. J. A., Gittelsohn, A. M., Booker, S. V., Krush, A. J., Yardley, J. H., & Luk, G. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162404 · Cited by 846 · see citing works
Overweight as an avoidable cause of cancer in Europe
Bergström, A., Pisani, P., Tenet, V., Wolk, A., & Adami, H. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999 · Cited by 772 · see citing works
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins, M., Schutte, M. E. M., Lü, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., et al. (1996) · PubMed · Cited by 642 · see citing works
The risk of upper gastrointestinal cancer in familial adenomatous polyposis
Offerhaus, G. J. A., Giardiello, F. M., Krush, A. J., Booker, S. V., Tersmette, A. C., Kelley, N., & Hamilton, S. R. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90322-p · Cited by 514 · see citing works
Murphy, K. M., Brune, K. A., Griffin, C. A., Sollenberger, J. E., Petersen, G. M., Bansal, R. K., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 435 · see citing works
Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome
Boardman, L. A., Thibodeau, S. N., Schaid, D. J., Lindor, N. M., McDonnell, S. K., Burgart, L. J., Ahlquist, D. A., Podratz, K. C., Pittelkow, M., & Hartmann, L. C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00004 · Cited by 420 · see citing works
Su, G. H., Hruban, R. H., Bansal, R. K., Bova, G. S., Tang, D. J., Shekher, M. C., Westerman, A. M., Entius, M. M., Goggins, M., Yeo, C. J., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65440-5 · Cited by 417 · see citing works
Silverman, D. T., SCHIFFMAN, M. H., Everhart, J., Goldstein, A. M., Lillemoe, K. D., Swanson, G. M., Schwartz, A. G., Brown, L. M., Greenberg, R. S., Schoenberg, J. B., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690607 · Cited by 397 · see citing works
Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S. L., Brody, L. C., Kaback, M. M., Haas, B. R., Norton, L., Borgen, P. I., Jhanwar, S. C., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-188 · Cited by 381 · see citing works
Tersmette, A. C., Petersen, G. M., Offerhaus, G. J. A., Falatko, F. C., Brune, K. A., Goggins, M., Rozenblum, E., Wilentz, R. E., Yeo, C. J., Cameron, J. L., et al. (2001) · PubMed · Cited by 307 · see citing works
Whelan, A. J., Bartsch, D. K., & Goodfellow, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331505 · Cited by 280 · see citing works
Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families
Phelan, C. M., Lancaster, J. M., Tonin, P. N., Gumbs, C. E., Cochran, C., Carter, R., Ghadirian, P., Perret, C., Moslehi, R., Dion, F., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-120 · Cited by 256 · see citing works
Lal, G., Liu, G., Schmocker, B., Kaurah, P., Özçelik, H., Narod, S. A., Redston, M. S., & Gallinger, S. (2000) · PubMed · Cited by 233 · see citing works
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
Özcelik, H., Schmocker, B., Nicola, N. D., Shi, X.-H., Langer, B., Moore, M. J., Taylor, B., Narod, S. A., Darlington, G., Andrulis, I. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-17 · Cited by 225 · see citing works
Meindl, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.1626 · Cited by 219 · see citing works
BRCA2 Is Inactivated Late in the Development of Pancreatic Intraepithelial Neoplasia
Goggins, M., Hruban, R. H., & Kern, S. E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65047-x · Cited by 213 · see citing works
Family history and the risk of liver, gallbladder, and pancreatic cancer.
Fernández, E., Vecchia, C. L., D’Avanzo, B., Negri, E., & Franceschi, S. (1994) · PubMed · Cited by 200 · see citing works
Schutte, M. E. M., da Costa, L. T., Hahn, S. A., Moskaluk, C. A., Hoque, A. T. M. S., Rozenblum, E., Weinstein, C. L., Bittner, M. L., Meltzer, P. S., & Trent, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5950 · Cited by 163 · see citing works
Systemic cancer and the FAMMM syndrome
Bergman, W., Watson, P. A., de Jong, J., Lynch, H., & Fusaro, R. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.209 · Cited by 160 · see citing works
Hruban, R. H., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Falatko, F., Yeo, C. J., & Kern, S. E. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s69 · Cited by 134 · see citing works
A New Susceptibility Locus for Autosomal Dominant Pancreatic Cancer Maps to Chromosome 4q32-34
Eberle, M. A., Pfützer, R. H., Pogue-Geile, K. L., Bronner, M. P., Crispin, D. A., Kimmey, M. B., Duerr, R. H., Kruglyak, L., Whitcomb, D. C., & Brentnall, T. A. (2002) · The American Journal of Human Genetics · doi:10.1086/339692 · Cited by 123 · see citing works
Pancreatic Cancer and the Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome
Lynch, H. T., & Fusaro, R. M. (1991) · Pancreas · doi:10.1097/00006676-199103000-00001 · Cited by 110 · see citing works
Neoplastic diseases in families of breast cancer patients.
Tulinius, H., Ólafsdóttir, G. H., Sigvaldason, H., Tryggvadóttír, L., & Bjarnadóttir, K. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.8.618 · Cited by 73 · see citing works
Applebaum-Shapiro, S. E., Kant, J. A., Whitcomb, D. C., & Ellis, I. H. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70241-8 · Cited by 56 · see citing works
Recent Discoveries in Cancer Genetics of Exocrine Pancreatic Neoplasia
Hahn, S. A., & Schmiegel, W. (1998) · Digestion · doi:10.1159/000007526 · Cited by 53 · see citing works
Familial pancreatic cancer (Part 1): Genetic pathology review.
Lynch, H. T., Lanspa, S. J., Fitzgibbons, R. J., Smyrk, T. C., Fitzsimmons, M. L., & McClellan, J. (1989) · PubMed · Cited by 40 · see citing works
Update of Familial Pancreatic Cancer in Germany
Bartsch, D. K., Sina‐Frey, M., Ziegler, A., Hahn, S. A., Przypadlo, E., Kress, R., Gerdes, B., & Rieder, H. (2001) · Pancreatology · doi:10.1159/000055853 · Cited by 37 · see citing works
The Incidence Study— Study Design and Methods
Cornoni, J. C. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310240050005 · Cited by 32 · see citing works
Gerdes, B., Kress, R., Rieder, H., Sina‐Frey, M., Przypadlo, E., Barth, P., Rehder, H., Hahn, S. A., Schmiegel, W., Rothmund, Μ., et al. (2002) · PubMed · Cited by 8 · see citing works
The incidence study--study design and methods
Cornoni, J. C. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.128.6.896 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Ozcelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, et al. Germline BRCA26174delT mutations in Ashkenazi Jewish pancreatic can- cer patients. Nat Genet 1997;16:17-8.
- White K, Held KR, Weber BH. A BRCA2 germ-line mutation in familial pancreatic carcinoma. Int J Cancer 2001;91:742-4.
- Rulyak S, Lowenfels A, Maissoneuve P, Brentnall T. Smoking as a risk factor in familial pancreatic cancer kindreds. Pancreatology 2001;1:551.
Cited by
Sorted by citations
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works
Vincent, A., Herman, J. M., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,613 · see citing works
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Rawla, P., Sunkara, T., & Gaduputi, V. (2019) · World Journal of Oncology · doi:10.14740/wjon1166 · Cited by 2,269 · see citing works
Li, D., Xie, K., Wolff, R. A., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,715 · see citing works
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Tempero, M. A., Malafa, M. P., Al-Hawary, M. M., Behrman, S. W., Benson, A. B., Cardin, D. B., Chiorean, E. G., Chung, V. M., Czito, B. G., Chiaro, M. D., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0017 · Cited by 1,319 · see citing works
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Klein, A. P. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00457-x · Cited by 1,258 · see citing works
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784 · see citing works
Epidemiology of pancreatic cancer: an overview
Raimondi, S., Maisonneuve, P., & Lowenfels, A. B. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.177 · Cited by 742 · see citing works
Hereditary Cancer Predisposition Syndromes
Garber, J. E., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.042 · Cited by 696 · see citing works
Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Griffin, C., Cameron, J. L., Yeo, C. J., Kern, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3823 · Cited by 678 · see citing works
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648 · see citing works
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S. S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646 · see citing works
Hampel, H., Bennett, R. L., Buchanan, A. H., Pearlman, R., & Wiesner, G. L. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.147 · Cited by 590 · see citing works
Inherited Susceptibility to Common Cancers
Foulkes, W. D. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802968 · Cited by 560 · see citing works
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Shindo, K., Yu, J., Suenaga, M., Fesharakizadeh, S., Cho, C., Macgregor-Das, A., Siddiqui, A., Witmer, P. D., Tamura, K., Song, T. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.3502 · Cited by 458 · see citing works
Early detection of pancreatic cancer
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., Li, D., Greenhalf, W., Jeon, C. Y., Koay, E. J., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30416-9 · Cited by 482 · see citing works
The Fanconi Anemia/BRCA pathway: new faces in the crowdPreprint
Kennedy, R. D., & D’Andrea, A. D. (2005) · Genes & Development · doi:10.1101/gad.1370505 · Cited by 464 · see citing works
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach
Canto, M. I., Goggins, M., Yeo, C. J., Griffin, C., Axilbund, J. E., Brune, K., Ali, S. Z., Jagannath, S., Petersen, G. M., Fishman, E. K., et al. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00244-7 · Cited by 448 · see citing works
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
Golan, T., Kanji, Z. S., Epelbaum, R., Devaud, N., Dagan, E., Holter, S., Aderka, D., Paluch–Shimon, S., Kaufman, B., Gershoni‐Baruch, R., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.418 · Cited by 437 · see citing works
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary
van Asperen, C. J., Brohet, R. M., Meijers-Heijboer, E. J., Hoogerbrugge, N., Verhoef, S., Vasen, H. F. A., Ausems, M. G. E. M., Menko, F. H., Gómez-García, E. B., Klijn, J. G. M., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028829 · Cited by 419 · see citing works
Biology and management of pancreatic cancer
Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2007) · Postgraduate Medical Journal · doi:10.1136/gut.2006.103333 · Cited by 419 · see citing works
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
Liede, A., Karlan, B., & Narod, S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 431 · see citing works
Holter, S., Borgida, A., Dodd, A., Grant, R., Semotiuk, K., Hedley, D., Dhani, N., Narod, S., Akbari, M., Moore, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7401 · Cited by 398 · see citing works
Susceptibility Pathways in Fanconi's Anemia and Breast Cancer
D’Andrea, A. D. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809889 · Cited by 380 · see citing works
Epidemiology and risk factors for pancreatic cancer
Lowenfels, A. B., & Maisonneuve, P. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.10.001 · Cited by 635 · see citing works
Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
Petrucelli, N., Daly, M. B., & Feldman, G. L. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181d38f2f · Cited by 340 · see citing works
Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection
Becker, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11182 · Cited by 331 · see citing works
Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors1
Cleary, S. P., Gryfe, R., Guindi, M. M., Greig, P. D., Smith, L., Mackenzie, R., Strasberg, S. S., Hanna, S. S., Taylor, B., Langer, B., et al. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.01.008 · Cited by 322 · see citing works
Current standards of surgery for pancreatic cancer
Alexakis, N., Halloran, C. M., Raraty, M. G. T., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004) · British journal of surgery · doi:10.1002/bjs.4794 · Cited by 316 · see citing works
Advances in counselling and surveillance of patients at risk for pancreatic cancer: Table 1
Brand, R. E., Lerch, M. M., Rubinstein, W. S., Neoptolemos, J. P., Whitcomb, D. C., Hruban, R. H., Brentnall, T. A., Lynch, H. T., & Canto, M. I. (2007) · Gut · doi:10.1136/gut.2006.108456 · Cited by 319 · see citing works
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., Farmer, M. B., Friedman, S., Garber, J. E., Khan, S., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0018 · Cited by 292 · see citing works
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
Kennedy, R. D., & D’Andrea, A. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4171 · Cited by 283 · see citing works
PALB2 mutations in European familial pancreatic cancer families
Slater, E., Langer, P., Niemczyk, E., Strauch, K., Butler, J., Habbe, N., Neoptolemos, J., Greenhalf, W., & Bartsch, D. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01425.x · Cited by 278 · see citing works
The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Brune, K. A., de Andrade, M., Goggins, M., Rothenmund, H., Gallinger, S., Klein, A. P., Petersen, G. M., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0783 · Cited by 273 · see citing works
Update on Familial Pancreatic Cancer
Hruban, R. H., Canto, M. I., Goggins, M., Schulick, R. D., & Klein, A. P. (2010) · Advances in Surgery · doi:10.1016/j.yasu.2010.05.011 · Cited by 269 · see citing works
Fanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden, M. S., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2003) · PubMed · Cited by 262 · see citing works
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Zhu, H., Wei, M., Xu, J., Hua, J., Chen, L., Meng, Q., Zhang, Y., Liu, J., Zhang, B., Yu, X., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01167-9 · Cited by 258 · see citing works
Lowery, M. A., Kelsen, D. P., Stadler, Z. K., Yu, K. H., Janjigian, Y. Y., Ludwig, E., D’Adamo, D. R., Salo‐Mullen, E. E., Robson, M. E., Allen, P. J., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0185 · Cited by 245 · see citing works
Permuth‐Wey, J., & Egan, K. M. (2008) · Familial Cancer · doi:10.1007/s10689-008-9214-8 · Cited by 232 · see citing works
Shi, C., Hruban, R. H., & Klein, A. P. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.365 · Cited by 226 · see citing works
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.
Friedenson, B. (2005) · PubMed Central · Cited by 224 · see citing works
Nielsen, M. F. B., Mortensen, M. B., & Detlefsen, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i9.2678 · Cited by 220 · see citing works
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
du Rieu, M. C., Torrisani, J., Sèlves, J., Saati, T. A., Souque, A., Dufresne, M., Tsongalis, G. J., Suriawinata, A. A., Carrère, N., Buscail, L., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.137364 · Cited by 217 · see citing works
PancPRO: Risk Assessment for Individuals With a Family History of Pancreatic Cancer
Wang, W., Chen, S., Brune, K. A., Hruban, R. H., Parmigiani, G., & Klein, A. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2452 · Cited by 216 · see citing works
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010
Sharma, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i7.867 · Cited by 214 · see citing works
Molecular markers of early pancreatic cancer
Goggins, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.19.711 · Cited by 214 · see citing works
DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease
Matsubayashi, H., Canto, M. I., Sato, N., Klein, A. P., Abe, T., Yamashita, K., Yeo, C. J., Kalloo, A. N., Hruban, R. H., & Goggins, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2664 · Cited by 213 · see citing works
BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
Ferrone, C. R., Levine, D. A., Tang, L. H., Allen, P. J., Jarnagin, W. R., Brennan, M. F., Offit, K., & Robson, M. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5546 · Cited by 206 · see citing works
Verna, E. C., Hwang, C., Stevens, P. D., Rotterdam, H., Stavropoulos, S. N., Sy, C. D., Prince, M. A., Chung, W. K., Fine, R. L., Chabot, J. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3209 · Cited by 201 · see citing works
Precursors to Pancreatic Cancer
Hruban, R. H., Maitra, A., Kern, S. E., & Goggins, M. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.08.012 · Cited by 203 · see citing works
Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
Stoffel, E. M., McKernin, S. E., Brand, R. E., Canto, M. I., Goggins, M., Moravek, C., Nagarajan, A., Petersen, G. M., Simeone, D. M., Yurgelun, M. B. B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.01489 · Cited by 205 · see citing works
Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer
Whitcomb, D. C. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00115.2004 · Cited by 197 · see citing works
Diagnosis and management of pancreatic cancer
Kanji, Z. S., & Gallinger, S. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121368 · Cited by 197 · see citing works
New biomarkers and targets in pancreatic cancer and their application to treatment
Costello, E., Greenhalf, W., & Neoptolemos, J. P. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.119 · Cited by 192 · see citing works
Koorstra, J.-B. M., Hustinx, S. R., Offerhaus, G. J. A., & Maitra, A. (2008) · Pancreatology · doi:10.1159/000123838 · Cited by 180 · see citing works
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
Tempero, M. A., Behrman, S. W., Ben‐Josef, E., Benson, A. B., Cameron, J. L., Casper, E. S., Hoffman, J. P., Karl, R. C., Kim, P., Koh, W., et al. (2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0035 · Cited by 181 · see citing works
Pathology of hereditary breast cancer
van der Groep, P., van der Wall, E., & van Diest, P. J. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0010-3 · Cited by 180 · see citing works
Kennedy, R. D., Chen, C. C., Stuckert, P., Archila, E. M., la Vega, M. A. D., Moreau, L. A., Shimamura, A., & D’Andrea, A. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31245 · Cited by 174 · see citing works
Risk factors for pancreatic cancer
Lowenfels, A. B., & Maisonneuve, P. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20461 · Cited by 175 · see citing works
Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben‐Josef, E., Benson, A. B., Berlin, J. D., Cameron, J. L., Casper, E. S., Cohen, S. J., Duff, M., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0073 · Cited by 166 · see citing works
Skoulidis, F., Cassidy, L. D., Pisupati, V., Jonasson, J. G., Bjarnason, H., Eyfjord, J. E., Karreth, F. A., Lim, M., Barber, L. M., Clatworthy, S. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.015 · Cited by 167 · see citing works
Iacobuzio–Donahue, C. A. (2011) · Gut · doi:10.1136/gut.2010.236026 · Cited by 158 · see citing works
Familial pancreatic cancer—current knowledge
Bartsch, D. K., Gress, T. M., & Langer, P. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.111 · Cited by 151 · see citing works
Brune, K. A., & Klein, A. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-69252-4_5 · Cited by 149 · see citing works
Detecting Early Pancreatic Cancer: Problems and Prospects
Chari, S. T. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.05.005 · Cited by 191 · see citing works
Molecular Signatures of Pancreatic Cancer
Hong, S., Park, J. Y., Hruban, R. H., & Goggins, M. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0566-ra.1 · Cited by 146 · see citing works
Genome-Wide Association Study of Pancreatic Cancer in Japanese Population
Low, S., Kuchiba, A., Zembutsu, H., Saito, A., Takahashi, A., Kubo, M., Daigo, Y., Kamatani, N., Chiku, S., Totsuka, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011824 · Cited by 145 · see citing works
Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Boardman, L., McWilliams, R. R., de Andrade, M., & Petersen, G. M. (2005) · Cancer Research · doi:10.1158/0008-5472.383.65.2 · Cited by 144 · see citing works
Pancreatic Cancer Genetic Epidemiology Consortium
Petersen, G. M., de Andrade, M., Goggins, M., Hruban, R. H., Bondy, M. L., Korczak, J. F., Gallinger, S., Lynch, H. T., Syngal, S., Rabe, K. G., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0734 · Cited by 141 · see citing works
Demographics, Epidemiology, and Inheritance of Pancreatic Ductal Adenocarcinoma
Yeo, T. P. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.002 · Cited by 136 · see citing works
Identifying people at a high risk of developing pancreatic cancer
Klein, A. P. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3420 · Cited by 136 · see citing works
Early detection and prevention of pancreatic cancer: Is it really possible today?
Chiaro, M. D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12118 · Cited by 135 · see citing works
Abramovitz, L., Rubinek, T., Ligumsky, H., Bose, S., Barshack, I., Avivi, C., Kaufman, B., & Wolf, I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2749 · Cited by 134 · see citing works
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies
Chiaravalli, M., Reni, M., & O'Reilly, E. M. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.08.007 · Cited by 134 · see citing works
Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors
Ushio, J., Kanno, A., Ikeda, E., Ando, K., Nagai, H., Miwata, T., Kawasaki, Y., Tada, Y., Yokoyama, K., Numao, N., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030562 · Cited by 132 · see citing works
Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells
van der Heijden, M. S., Brody, J. R., Gallmeier, E., Cunningham, S. C., Dezentjé, D. A., Shen, D., Hruban, R. H., & Kern, S. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63329-9 · Cited by 129 · see citing works
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience
Schneider, R., Slater, E. P., Sina, M., Habbe, N., Fendrich, V., Matthäi, E., Langer, P., & Bartsch, D. K. (2011) · Familial Cancer · doi:10.1007/s10689-010-9414-x · Cited by 143 · see citing works
Pancreatic Cancer: Pathobiology, Treatment Options, and Drug Delivery
Li, J., Wientjes, M. G., & Au, J. L. ‐. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9181-5 · Cited by 120 · see citing works
Giri, V. N., & Beebe‐Dimmer, J. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.08.001 · Cited by 117 · see citing works
DNA Double Strand Break Repair: A Radiation Perspective
Kavanagh, J. N., Redmond, K. M., Schettino, G., & Prise, K. M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5151 · Cited by 111 · see citing works
Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years
Lüttges, J., Stigge, C., Pacena, M., & Klöppel, G. (2003) · Cancer · doi:10.1002/cncr.11860 · Cited by 110 · see citing works
Familial pancreatic cancer: Concept, management and issues
Matsubayashi, H., Takaori, K., Morizane, C., Maguchi, H., Mizuma, M., Takahashi, H., Wada, K., Hosoi, H., Yachida, S., Suzuki, M., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i6.935 · Cited by 109 · see citing works
BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects
Wong, W., Raufi, A. G., Safyan, R. A., Bates, S. E., & Manji, G. A. (2020) · Cancer Management and Research · doi:10.2147/cmar.s211151 · Cited by 109 · see citing works
Early Detection of Pancreatic Cancer: Why, who, and how to Screen
Klapman, J. B., & Malafa, M. P. (2008) · Cancer Control · doi:10.1177/107327480801500402 · Cited by 109 · see citing works
Grover, S., & Syngal, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.012 · Cited by 109 · see citing works
The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families
Pilarski, R. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238977 · Cited by 107 · see citing works
Anticipation in familial pancreatic cancer
McFaul, C. D., Greenhalf, W., Earl, J., Howes, N., Neoptolemos, J. P., Kress, R., Sina-Frey, M., Rieder, H., Hahn, S., & Bartsch, D. K. (2006) · Gut · doi:10.1136/gut.2005.065045 · Cited by 132 · see citing works
Inherited pancreatic cancer syndromes
Solomon, S., Das, S., Brand, R., & Whitcomb, D. C. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318278c4a6 · Cited by 120 · see citing works
Genetic predisposition to pancreatic cancer
Ghiorzo, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i31.10778 · Cited by 102 · see citing works
Role of BRCA1 and BRCA2 mutations in pancreatic cancer
Greer, J. B., & Whitcomb, D. C. (2006) · Gut · doi:10.1136/gut.2006.101220 · Cited by 101 · see citing works
Assessing BRCA Carrier Probabilities in Extended Families
Barcenas, C. H., Hosain, G. M., Arun, B. K., Zong, J., Zhou, X., Chen, J., Cortada, J. M., Mills, G. B., Tomlinson, G. E., Miller, A. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2368 · Cited by 100 · see citing works
Stadler, Z. K., Salo‐Mullen, E. E., Patil, S. M., Pietanza, M. C., Vijai, J., Saloustros, E. S., Hansen, N. A. L., Kauff, N. D., Kurtz, R. C., Kelsen, D. P., et al. (2011) · Cancer · doi:10.1002/cncr.26191 · Cited by 98 · see citing works
Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry
Mocci, E., Milne, R. L., Méndez-Villamil, E. Y., Hopper, J. L., John, E. M., Andrulis, I. L., Chung, W. K., Daly, M. B., Buys, S. S., Malats, N., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0195 · Cited by 97 · see citing works
Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia
Goggins, M. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.05.003 · Cited by 96 · see citing works
Rieder, H., & Bartsch, D. K. (2004) · Familial Cancer · doi:10.1023/b:fame.0000026822.67291.a1 · Cited by 96 · see citing works
BRCA1 and pancreatic cancer: pedigree findings and their causal relationships
Lynch, H. T., Deters, C. A., Snyder, C., Lynch, J. F., Villeneuve, P. J. A., Silberstein, J., Martin, H., Narod, S. A., & Brand, R. E. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.01.032 · Cited by 95 · see citing works
Molecular classification of neoplasms of the pancreas
Hruban, R. H., & Adsay, V. N. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.01.008 · Cited by 93 · see citing works
Current status of molecular markers for early detection of sporadic pancreatic cancer
Chakraborty, S., Baine, M. J., Sasson, A. R., & Batra, S. K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.09.002 · Cited by 90 · see citing works
Jimeno, A., & Hidalgo, M. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0005 · Cited by 92 · see citing works
- Authors
- Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., Campra, D., Grutzmann, R., Rehder, H., Rothmund, M., Schmiegel, W., Neoptolemos, J. P., & Bartsch, D. K.
- Affiliations
- Universitätsklinikum Knappschaftskrankenhaus Bochum (DE)
- Corresponding author
- Hahn, S. A.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-05
- Volume
- 95
- Issue
- 3
- Pages
- 214-221
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W1544246953
- Cited by
- 480
- References
- 40
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 11 · 2023: 13 · 2022: 21 · 2021: 19 · 2020: 11 · 2019: 14 · 2018: 16 · 2017: 21 · 2016: 33 · 2015: 24 · 2014: 23 · 2013: 25 · 2012: 35
- FWCI
- 13.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- BRCA2, germline mutations, familial pancreatic cancer, pancreatic ductal adenocarcinoma, frameshift mutation, unclassified variants, hereditary cancer predisposition, molecular genetic testing, genetic counseling, European family
- MeSH terms
- Adult, Aged, DNA, Neoplasm, Europe, Female, Germany, Humans, Lymphocytes, Male, Middle Aged, Pancreatic Neoplasms, Pedigree, Phenotype, Registries, Frameshift Mutation, Sequence Analysis, DNA, Germ-Line Mutation, Genetic Predisposition to Disease, Genes, BRCA2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
